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Abstract We purified extensively 25-hydroxyvitamin D 3 
la-hydroxylase (calcidiol, NADPH: oxygen oxidoreductase 
(1-hydroxylating), EC 1.14.13.13) from kidney mitochondria of 
rachitic rats and disclosed its peculiar properties as a P450. The 
final preparation was identified as a 55 kDa protein having an 
intense absorption at 417 nm characteristic of P450. The specific 
activity was 4.8 nmol/min/mg of protein indicating a 350-fold 
purification. Specific content of P450 was 1.1 nmol/mg of protein 
and turnover number was 4.4 min - 1 . 
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1. Introduction 
25-Hydroxyvitamin D 3 la-hydroxylase ( la-hydroxylase) 
catalyzes la-hydroxylat ion of 25-hydroxyvitamin D 3 [1]. In 
1974, Henry et al. [2] showed evidence that the enzyme was 
a P450. Although purification of this enzyme has been at-
tempted from mitochondria of the chicken and pig kidney, 
convincing evidence of even partial purification of the enzyme 
has been scarce. Owing to the paucity and extreme lability of 
the enzyme, purification has been considered as a largely in-
tractable problem [3]. 
So far, purification of the enzyme has not been attempted 
from the rat because of the inhibitory factor(s) in mammalian 
tissues [4]. Contrary to these predecessors, we chose the rat 
kidney as the enzyme source, because we considered that any 
inhibitor(s) existing in the starting material might be removed 
during the course of purification. This was proved to be true. 
In this experiment we purified the enzyme to an extreme ex-
tent and elucidated the peculiar properties of the enzyme. 
2. Materials and methods 
2.1. Materials 
Pepstatin and leupeptin were purchased from Wako (Osaka, Ja-
pan), CHAPS from Sigma (St. Louis, MO), hydroxyapatite from 
Bio-Rad (Richmond, CA), octyl-Sepharose CL-4B from Pharmacia 
(Uppsala, Sweden), TSK-gel DEAE-5PW and Toyopearl HW-40 
from Tosoh (Tokyo, Japan), and PEG 6000 from Nacalai (Kyoto, 
Japan). All other reagents were of the highest grade commercially 
available. Adrenodoxin and NADPH-adrenodoxin reductase were 
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prepared according to the methods of Suhara et al. and Hiwatashi 
et al., respectively [5,6]. Vitamin D-deficient rat diets were from Har-
lan Teklad (Madison, WI). 
2.2. Animals 
Weanling male rats (Sprague-Dawley strain) were fed the vitamin 
D-deficient diet containing replete calcium (for 4 weeks) and deplete 
calcium (for another 2 weeks) according to the method of Paulson 
and DeLuca [7]. 
2.3. Preparation of a mitochondrial and nuclear fraction 
All buffer solutions used in the following procedure contained 20% 
glycerol, 1 mM DTT, 1 mM EDTA, and 2 μg/ml each of pepstatin 
and leupeptin unless otherwise stated. Mitochondria were prepared 
from twenty rachitic rats according to the method described elsewhere 
(Eto et al., to be published). 
2.4. Enzyme purification 
The above preparation was suspended in 100 mM potassium phos-
phate buffer (pH 7.4) containing the above reagents, to which 10% 
CHAPS was added dropwise to give a final CHAPS/protein ratio of 
1:1 (w/w) under mild stirring on ice. After this, the mixture was kept 
stirring for another 30 min and then centrifuged at 100 000 Xg for 1 h. 
The supernatant was fractionated with 50% PEG according to the 
method described by Coon et al. [8]. A fraction precipitated with 8-
15% PEG was re-dissolved in the phosphate buffer (pH 7.4) contain-
ing 0.2% CHAPS. The re-dissolved solution was diluted with 20% 
glycerol containing 1 mM EDTA, 1 mM DTT, and 2 μg/ml each of 
pepstatin and leupeptin to bring concentration of the phosphate buff-
er to 40 mM and that of CHAPS to 0.08%. The diluted enzyme 
solution was then immediately applied to a hydroxyapatite column 
(2.5 X10 cm) that had been equilibrated with 40 mM phosphate buffer 
containing 0.08% CHAPS (EDTA was omitted). The column was 
washed with the equilibration buffer. The non-bound fraction that 
contained enzyme activity was pooled and concentrations of the buffer 
and CHAPS were increased to 100 mM and 0.2%, respectively, by 
adding 0.5 M potassium phosphate buffer (pH 7.4) containing 1% 
CHAPS. Then, the solution (ca. 90 ml in total) was applied to an 
octyl-Sepharose CL-4B column (1.5 X 10 cm) equilibrated beforehand 
with 100 mM phosphate buffer containing 0.2% CHAPS. The column 
was subsequently washed with the equilibration buffer, 40 mM phos-
phate buffer containing 0.2% CHAPS, and 20 mM phosphate buffer 
containing 0.5% CHAPS. Proteins were eluted with the same buffer 
except CHAPS concentration (1%). The effluents showing the enzyme 
activity were pooled. The buffer was exchanged to 30 mM Tris-HCl 
(pH 7.4) containing 0.5% CHAPS using a Toyopearl HW-40 column. 
A half aliquot of the fraction was applied to a TSK-gel DEAE-5PW 
column (7.5 X150 mm) equilibrated beforehand with the same buffer. 
The column was washed with the equilibration buffer and proteins 
were eluted with linear gradients of both NaCl (0-0.1 M, from 0 to 
20 min; 0.1-0.3 M, from 20 to 140 min) and CHAPS (0.5-0.8%, from 
0 to 20 min; 0.8-1.4%, from 20 to 140 min). The flow rate of the 
anion exchange column chromatography was 0.4 ml/min, and effluents 
were monitored at 417 nm and 280 nm. 
All the above procedures were carried out in the cold (0-4°C) and 
any fractions containing enzyme activity were stored at —30°C during 
intervals between operations. 
2.5. Enzyme assay 
la-Hydroxylase was assayed by a reconstitution method using sat-
urating amounts of adrenodoxin and NADPH-adrenodoxin reductase 
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Fig. 1. Stability of la-hydroxylase. The 100000 Xg supernatant of 
the solubilized suspension was divided into two fractions, of which 
one was stored at 4°C (·) and the other at —30°C (o). Aliquote of 
each fraction were subjected to enzyme assay after definite time in-
tervals. 
as the electron transferring proteins according to the method of Eto et 
al. (to be published). 
2.6. Other methods 
Protein concentration was determined according to the method of 
Lowry et al. [9] using bovine serum albumin as the standard. Buffer-
change and desalting were carried out by gel filtration chromatogra-
phy using a Toyopearl HW-40 column. P450 concentration was de-
termined from absorption at 417 nm assuming an extinction coeffi-
cient of 100 mM-1 cm-1. SDS-PAGE was performed according to the 
method of Laemmli [10]. 
3. Results 
3.1. Enzyme stability 
In the early stage of purification, the enzyme seemed to be 
more labile than other P450s. We therefore tried to find a 
condition at which the enzyme is stabilized using the 
lOOOOOXg supernatant of the solubilized mitochondria. As 
shown in Fig. 1, keeping the lOOOOOXg supernatant in the 
cold (0-4°C) resulted in rapid loss of the enzyme activity. In 
contrast, when it was kept at — 30°C, the enzyme loss was 
markedly lessened. The enzyme activity loss was dependent 
on temperature. A decrease of 30 degrees in temperature 
lessened the enzyme activity loss to one eighth. The final 
preparation was more stable standing at — 30°C for six 
months or longer without significant loss of enzyme activity. 
3.2. Purification of 25-hydroxyvitamin D$ la-hydroxylase 
Purification of the enzyme was performed as described in 
Section 2. Hydroxyapatite column chromatography was car-
ried out under a condition that the enzyme was not adsorbed 
but eluted in the non-bound fraction. In contrast, many other 
proteins and nucleic acids were adsorbed to the column, re-
sulting in a significant increase of specific activity at this stage. 
This method was found to be much better than the conven-
tional one in which PEG was removed before chromatogra-
phies. The non-bound fraction was then applied to an octyl-
Sepharose column. The column was then washed stepwise 
with three different buffers. The enzyme was eluted with 
20 mM phosphate buffer containing 1% CHAPS. The elution 
profile is shown in Fig. 2A. As shown in the figure, the en-
zyme was eluted as a single peak. A half aliquot of the efflu-
ents showing the enzyme activity was subjected to HPLC us-
ing a DEAE-5PW column. Proteins were eluted with linear 
gradients of both NaCl and CHAPS (Fig. 2B). The enzyme 
was eluted as a single peak at an elution volume correspond-
ing to 0.15 M NaCl and 1% CHAPS. This peak coincided 
with one of the peaks depicted by absorption at 417 nm. 
The effluents showing enzyme activity were pooled and stored 
at -30°C. 
The final preparation catalyzed la-hydroxylation. Specific 
activity of the partially purified enzyme was 4.8 nmol of 
product formed/min/mg protein. Specific P450 content was 
1.1 nmol/mg of protein and turnover number 4.4 min- 1 . Table 
1 summarizes the results of the purification procedures. Over-
all purification from the solubilized mitochondria was 350-
fold. The purified enzyme was, however, still inhomogeneous 
judging from the SDS-polyacrylamide gel electrophoretogram, 
which showed few bands in addition to the one at 55 kDa 
(data not shown). The 55 kDa protein was found only in the 
Chromatographie fractions that showed the enzyme activity. It 
was therefore identified as la-hydroxylase. 


















Fig. 2. Elution profile of la-hydroxylase of rat kidney mitochondria from an octyl-Sepharose CL-4B (A) and that from an HPLC (B) column. 
The enzyme solution applied to the octyl-Sepharose column was the pass through fraction from the hydroxyapatite column and that applied to 
the HPLC column was the eluate showing the enzyme activity from the octyl-Sepharose column. A: Buffers were changed at elution volume in-
dicated by arrows (a, 100 mM KPb and 0.2% CHAPS; b, 40 mM KPb and 0.2% CHAPS; c, 20 mM KPb and 0.5% CHAPS; d, 20 mM KPb 
and 1% CHAPS). Enzyme was assayed with 20 μΐ of the effluent. · , la-hydroxylase activity; , absorbance at 417 nm; , absorbance 
at 280 nm. B: The enzyme was assayed using 20 μΐ of the effluent. · , la-hydroxylase activity; , absorbance at 417 nm; , NaCl con-
centration; , CHAPS concentration. 
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4. Discussion 
Fig. 3. Electrophoretogram of the solubilized kidney mitochondria 
of rachitic rats and the partially purified la-hydroxylase. Samples 
underwent electrophoresis on a 12% SDS-polyacrylamide gel and 
were stained with silver. Lane 1, molecular weight standards (ß-ga-
lactosidase: Mr 116400; fructose-6-phosphate kinase: Mr 85200; 
glutamate dehydrogenase : Μτ 55600; aldolase: Μτ 39200; triose-
phosphate isomerase: MT 26600); lane 2, lOOOOOxg supernatant of 
the solubilized mitochondria; lane 3, the sample obtained by the 
modified method (see text). The amount of proteins applied were 
3.0 μg and 0.6 μg in lanes 2 and 3, respectively. 
showing fewer bands in addition to the major one at 55 kDa 
was obtained (Fig. 3). Modification was as follows: A fraction 
precipitated between 8-18% (instead of 15%) PEG was sub-
jected to hydroxyapatite chromatography. The effluent show-
ing enzyme activity was then applied to the octyl-Sepharose 
column. The enzyme was eluted with 20 mM phosphate buffer 
containing 0.5% CHAPS (without washing the column with 
equilibration buffer). The enzyme eluted just after the pass 
through fraction was subjected to anion exchange HPLC. 
3.3. Reconstitution of the enzyme activity 
la-Hydroxylase activity was reconstituted with the partially 
purified enzyme, adrenodoxin, NADPH-adrenodoxin reduc-
tase, and NADPH. The omission of either the enzyme or 
the electron transferring proteins resulted in complete loss of 
activity. 
3.4. Absorption spectrum 
The absorption spectrum of the final preparation is shown 
in Fig. 4. An intense peak was observed at 417 nm which was 
recognized to correspond to the γ band of P450. In contrast, 
this preparation did not show any absorption at 403 nm. The 
result was at variance with that of Mandel et al. [11] who 
observed an intense peak at 403 nm in an absorption spec-
trum of the la-hydroxylase purified from the rachitic chicken 
kidney. 
Recently, we found that an inhibitory factor(s) for la-hy-
droxylase in the rat kidney could be largely removed from the 
solubilized mitochondria by ultracentrifugation, and estab-
lished a sensitive assay method of the enzyme (Eto et al., to 
be published). An attempt to purify the enzyme from kidney 
mitochondria of rachitic rats employing this new assay meth-
od was, however, severely hampered by high lability of the 
enzyme not experienced before. Enzyme activity disappeared 
during the course of purification. In due course, we found that 
the lability was affected by several factors. (1) The solubilizing 
agent: Because P450 is a membrane-bound enzyme, it should 
be solubilized by any detergent before purification. It was 
found that cholate, widely used for solubilizing P450s, was 
not adequate because it inhibited markedly the enzyme activ-
ity. (2) Detergents : It is well known that detergent is required 
for keeping hydrophobic proteins in the solubilized state dur-
ing purification. Without detergent, hydrophobic proteins 
easily adhere to glassware's or column contents. However, 
none of the detergents usually applied in the purification of 
many P450s, e.g. Lubrol, Emulgen, was adequate. The deter-
gents inactivated the enzyme almost completely. (3) Some 
unknown factor(s) deteriorating the enzyme: Although the 
factor(s) seemed to be somewhat like proteinase, inactivation 
was scarcely suppressed by increasing the amount of protein-
ase inhibitors such as pepstatin and leupeptin. (4) Dialysis: 
Dialysis was found to be fatal to the enzyme activity. In fact, 
dialysis overnight in the cold destroyed more than 90% of the 
enzyme activity, though it was not clear whether dialysis itself 
or keeping the solution in the cold caused deterioration. The 
fact that the enzyme is affected by these factor(s) seems to go 
against common sense in P450 purification. The enzyme 
would not have been purified if one followed the generally 
established method for purifying P450s. These unusual prop-
erties together with the extreme low abundance of the enzyme 
may be the reasons why the enzyme has not been purified for 
such a long time since it was found in 1970 [12]. 
We either solved or evaded these problems as follows: The 
first problem was already solved in this laboratory by employ-
ing CHAPS as a solubilizing agent (Eto et al., to be pub-
lished). It solubilized mitochondria effectively without inhibit-
ing enzyme activity. The second problem was solved also by 
using CHAPS, which was effective in keeping the enzyme 
solubilized. The third problem was circumvented by carrying 
out all the operations within a short time and keeping any 
fractions containing the enzyme at — 30°C during intervals 
between operations (e.g. at night and on weekends). The 
fourth problem was evaded by applying a gel filtration tech-
nique using a Toyopearl column instead of dialysis. Thus, we 
Table 1 
Partial purification of la-hydroxylase from kidneys of rachitic rats 
Preparation Total protein (mg) la-Hydroxylase Total P450 (pmol) 





















aDetermined from absorption at 280 nm assuming an extinction coefficient as 1 (mg/ml) ' c m '. 
bSpecific P450 content calculated from absorbance at 417 nm in Fig. 4 and that at 280 nm was multiplied by the total protein. 
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Fig. 4. Absorption spectrmn of the oxidized form of the partially 
purified la-hydroxylase. Protein concentration was 8 μ§/100 μΐ in 
30 mM Tris-HCl buffer (pH 7.4) containing 20% glycerol. 
solved or evaded these problems. Then, purifying la-hydrox-
ylase was reduced to a matter of purification of a common 
P450 though the enzyme is scarce. Finally, the enzyme was 
purified 350-fold. Judging from SDS-PAGE, however, the fi-
nal preparation was still inhomogeneous, revealing few bands 
on the electrophoretogram. Yet, the fact that the protein 
showing a band at 55 kDa was found only in the Chromato-
graphie fractions which had the enzyme activity established 
that la-hydroxylase is a 55 kDa protein. This value is similar 
to the molecular weight reported for the enzymes of the chick-
en, rat, and mouse, though their methods were different from 
ours [13-15]. When purification was slightly modified, a prep-
aration showing better electrophoretogram was obtained. 
However, the modified method was rather capricious, at times 
resulting in lower specific activity and yield. Accordingly, this 
method was not adopted as a standard method. Further at-
tempts to purify the final preparation of either method re-
sulted in considerable enzyme loss. 
In conclusion, we have extensively purified la-hydroxylase 
of rat kidney mitochondria and isolated a 55 kDa protein 
showing the Soret band at 417 nm characteristic of P450 
and elucidated the peculiar properties of the enzyme. It is 
not clear whether the unusually rapid decrease in enzyme 
activity is related to the regulation of the enzyme. It may 
also be interesting that in purifying this enzyme several inno-
vations were adopted, some of which might be applicable for 
purifying other enzymes which resist being purified. 
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